BioNTech

BioNTech is a German biotech company that became famous for developing one of the first COVID-19 vaccines. They use a technology called mRNA, which is like a recipe for cells to make proteins. For COVID, they used it to teach the body to make a harmless piece of the virus, triggering an immune response. Now, they're applying the same technology to fight cancer. They're developing personalized vaccines that can train the immune system to attack tumors, and they're also working on other types of cancer treatments like antibody-drug conjugates (which are like guided missiles that deliver chemotherapy directly to cancer cells) and bispecific antibodies (which bring immune cells and cancer cells together). They have many early-stage trials in various cancers, but it's still early days. They have a lot of money from the COVID vaccine, so they can afford to take risks. If any of their cancer treatments work, it could be huge, but it's a high-risk, high-reward situation.